Your browser doesn't support javascript.
loading
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab
González Cao, M; Viteri, S; Garrán, C; Nieto, Y; Aristu, J; Ponz, M; Martín Algarra, S.
Affiliation
  • González Cao, M; Clínica Universitaria de Navarra. Pamplona. Spain
  • Viteri, S; Clínica Universitaria de Navarra. Pamplona. Spain
  • Garrán, C; Clínica Universitaria de Navarra. Pamplona. Spain
  • Nieto, Y; Clínica Universitaria de Navarra. Pamplona. Spain
  • Aristu, J; Clínica Universitaria de Navarra. Pamplona. Spain
  • Ponz, M; Clínica Universitaria de Navarra. Pamplona. Spain
  • Martín Algarra, S; Clínica Universitaria de Navarra. Pamplona. Spain
Clin. transl. oncol. (Print) ; 9(2): 119-120, feb. 2007. ilus
Article in English | IBECS | ID: ibc-123278
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
We report here a taxol-bevacizumab-responsive metastatic melanoma case. Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained (AU)
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Database: IBECS Main subject: Paclitaxel / Angiogenesis Inhibitors / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents, Phytogenic Limits: Adult / Female / Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2007 Document type: Article Institution/Affiliation country: Clínica Universitaria de Navarra/Spain
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Database: IBECS Main subject: Paclitaxel / Angiogenesis Inhibitors / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents, Phytogenic Limits: Adult / Female / Humans Language: English Journal: Clin. transl. oncol. (Print) Year: 2007 Document type: Article Institution/Affiliation country: Clínica Universitaria de Navarra/Spain